Induction of apoptosis by remoxipride metabolites in HL60 and CD34+/CD19− human bone marrow progenitor cells: potential relevance to remoxipride-induced aplastic anemia
- 16 July 1999
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 121 (3) , 253-265
- https://doi.org/10.1016/s0009-2797(99)00105-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity.Environmental Health Perspectives, 1996
- Metabolic basis of benzene toxicityEuropean Journal of Haematology, 1996
- Overview of benzene‐induced aplastic anaemiaEuropean Journal of Haematology, 1996
- Pharmacogenetics and blood dyscrasiasEuropean Journal of Haematology, 1996
- Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemiaBritish Journal of Haematology, 1995
- Adverse reaction reporting and new antipsychoticsThe Lancet, 1993
- Peroxidase activation of hydroquinone results in the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrowCarcinogenesis: Integrative Cancer Research, 1993
- Aplastic anaemia and remoxiprideThe Lancet, 1993
- A long‐term study of remoxipride in chronic schizophrenic patientsActa Psychiatrica Scandinavica, 1993
- Synthesis of 5-Substituted 5-Hydroxy-2-pyrrolidones, Metabolites of the Antipsychotic Benzamide Remoxipride.Acta Chemica Scandinavica, 1989